Inhibition of hepatitis B virus and human immunodeficiency virus (HIV-1) replication by Warscewiczia coccinea (Vahl) Kl. (Rubiaceae) ethanol extract

Natural Product Research

Volumn 25, Issue 16, 2011, Pages 1565-1569

  Quintero, A ^a,b   Fabbro, R ^a   Maillo, M ^b   Barrios, M ^a   Milano, M B ^b   Fernandez, A ^b   Williams, B ^b   Michelangeli, F ^b   Rangel, H R ^a   Pujol, F H ^a  

^a Instituto Venezolano de Investigaciones Cientificas Centro de Microbiologia y Biologia Celular   (Venezuela)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

antiretroviral; antiviral; hepatitis; HIV; plant extracts

Indexed keywords

ALCOHOL; ANTIVIRUS AGENT; EUTERPE PRECATORIA EXTRACT; JACARANDA COPAIA EXTRACT; JACARANDA OBTUSIFOLIA EXTRACT; PLANT EXTRACT; SENNA SILVESTRIS EXTRACT; UNCLASSIFIED DRUG; VOCHYSIA GLABERRIMA EXTRACT; WARSCEWICZIA COCCINEA EXTRACT; WATER;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; EUTERPE PRECATORIA; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; JACARANDA COPAIA; JACARANDA OBTUSIFOLIA; MEDICINAL PLANT; NONHUMAN; SENNA SILVESTRIS; VIRUS REPLICATION; VOCHYSIA GLABERRIMA; WARSCEWICZIA COCCINEA;

ANTIVIRAL AGENTS; CELL LINE, TRANSFORMED; ETHANOL; HEP G2 CELLS; HEPATITIS B VIRUS; HIV-1; HUMANS; PLANT EXTRACTS; RUBIACEAE; TIME FACTORS; VIRUS REPLICATION;

COCCOIDEA; EUTERPE PRECATORIA; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; JACARANDA; JACARANDA COPAIA; RUBIACEAE; SENNA; VOCHYSIA;

EID: 80053076847     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2010.535164     Document Type: Article

References (11)

1. Alexandre-Moreira, M.S., Piuvezam, M.R., Araú jo, C.C., & Thomas, G. (1999). Studies on the anti-inflammatory and analgesic activity of Curatella americana L. Journal of Ethnopharmacology, 67, 171-177. (Pubitemid 29421672)
2. Chattopadhyay, D., & Naik, T.N. (2007). Antivirals of ethnomedicinal origin: Structureactivity relationship and scope. Mini Reviews in Medicinal Chemistry, 7, 275-301. (Pubitemid 46488250)
3. Devesa, M., Rodr?́guez, C., Leó n, G., Liprandi, F., & Pujol, F.H. (2004). Clade analysis and surface antigen polymorphism of hepatitis B virus American genotypes. Journal of Medical Virology, 72, 377-384. (Pubitemid 38133978)
4. Ganem, D. (1991). Assembly of hepadnaviral virions and subviral particles. In W.S. Mason & C. Seeger (Eds.), Hepadnaviruses: molecular biology and pathogenesis. Current Topics in Microbiology and Immunology, 168, 61-83. New York: Springer-Verlag.
5. Hess, S.C., Brum, R.L., Honda, N.K., Cruz, A.B., Moretto, E., Cruz, R.B., . . . , Yunes, R.A. (1995). Antibacterial activity and phytochemical analysis of Vochysia divergens (Vochysiaceae). Journal of Ethnopharmacology, 47, 97-100.
6. Lu, X., Block, T.M., & Gerlich, W.H. (1996). Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line. Journal of Virology, 70, 2277-2285. (Pubitemid 26087590)
7. Martin, K.W., & Ernst, E. (2003). Antiviral agents from plants and herbs: A systematic review. Antiviral Therapy, 8, 77-90. (Pubitemid 36565887)
8. McMahon, B.J. (2005). Epidemiology and natural history of hepatitis B. Seminars in Liver Diseases, 25(Suppl. 1), 3-8. (Pubitemid 41254588)
9. Sells, M.A., Chen, M.L., & Acs, G. (1987). Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proceeding of the National Academy of Sciences USA, 84, 1005-1009. (Pubitemid 17031557)
10. Schalm, S.W., de Man, R.A., Heijtink, R.A., & Niesters, H.G. (1995). New nucleoside analogues for chronic hepatitis B. Journal of Hepatology, 22(Suppl. 1), 52-56.
11. Zoulim, F. (2001). Evaluation of novel strategies to combat hepatitis B virus targetting wildtype and drug-resistant mutants in experimental models. Antiviral Chemistry and Chemotherapy, 12(Suppl. 1), 131-142.